Crean; Christopher S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Crean; Christopher S..The latest application filed is for "cytoskeletal active rho kinase inhibitor compounds, composition and use".

Company Profile

0.11.10

Crean; Christopher S. - Pittsboro NC US
Crean; Christopher S. - Cary NC
Crean; Christopher S. - Apex NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,205 - Lampe , et al. December 10, 2	2013-12-10
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,604,218 - Lampe , et al. December 10, 2	2013-12-10
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20130012543 - LAMPE; John W. ; et al.	2013-01-10
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20120046275 - Lampe; John W. ; et al.	2012-02-23
Cytoskeletal active rho kinase inhibitor compounds, composition and use Grant 8,071,779 - Lampe , et al. December 6, 2	2011-12-06
Non-nucleotide compositions and method for treating pain Grant 7,749,980 - Plourde, Jr. , et al. July 6, 2	2010-07-06
Ophthalmic Formulation Of Rho Kinase Inhibitor Compound App 20100022517 - Richards; Lori A. ; et al.	2010-01-28
Degradation-resistant mononucleoside phosphate compounds Grant 7,612,047 - Douglass, III , et al. November 3, 2	2009-11-03
Degradation-resistant Mononucleoside Phosphate Compounds App 20090076256 - Douglass, III; James G. ; et al.	2009-03-19
Orally bioavailable compounds and methods for inhibiting platelet aggregation Grant 7,504,497 - Douglass, III , et al. March 17, 2	2009-03-17
Degradation-resistant mononucleoside phosphate compounds Grant 7,435,724 - Douglass, III , et al. October 14, 2	2008-10-14
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition And Use App 20080214614 - Lampe; John W. ; et al.	2008-09-04
Degradation-resistant mononucleoside phosphate compounds App 20070244068 - Douglass; James G. III ; et al.	2007-10-18
Non-nucleotide compositions and method for treating pain App 20070123544 - Plourde; Robert JR. ; et al.	2007-05-31
Orally bioavailable compounds and methods for inhibiting platelet aggregation App 20070093446 - Douglass; James G. III ; et al.	2007-04-26
Compositions for treating epithelial and retinal tissue diseases Grant 7,115,585 - Yerxa , et al. October 3, 2	2006-10-03
Method for treating pain Grant 6,881,725 - Yerxa , et al. April 19, 2	2005-04-19
Method for treating pain App 20030158147 - Yerxa, Benjamin R. ; et al.	2003-08-21
Compsoitions and methods for treating epithelia and retinal tissue diseases App 20030008834 - Yerxa, Benjamin R. ; et al.	2003-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.